

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.24916097 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.97664764 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.97664764 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.78698363 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.74936523 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.67103275 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.67103275 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.45765699 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 5.34815584 |
| 10 | positive thymic T cell selection (GO:0045059) | 5.31361519 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.28377888 |
| 12 | negative T cell selection (GO:0043383) | 5.10797174 |
| 13 | negative thymic T cell selection (GO:0045060) | 5.00476533 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 4.91360905 |
| 15 | leukocyte aggregation (GO:0070486) | 4.83939051 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.71316650 |
| 17 | response to interleukin-15 (GO:0070672) | 4.68569354 |
| 18 | regulation of B cell differentiation (GO:0045577) | 4.65878083 |
| 19 | positive T cell selection (GO:0043368) | 4.64963077 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.58118134 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.58118134 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.58118134 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.58118134 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.58118134 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.58118134 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.56852437 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 4.51603842 |
| 28 | T cell migration (GO:0072678) | 4.48314615 |
| 29 | detection of bacterium (GO:0016045) | 4.45570849 |
| 30 | detection of other organism (GO:0098543) | 4.45192023 |
| 31 | thymic T cell selection (GO:0045061) | 4.43644089 |
| 32 | response to peptidoglycan (GO:0032494) | 4.39646587 |
| 33 | T cell selection (GO:0045058) | 4.37310261 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 4.34428736 |
| 35 | interferon-gamma production (GO:0032609) | 4.34414537 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 4.07585058 |
| 37 | response to muramyl dipeptide (GO:0032495) | 4.02701591 |
| 38 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.01096136 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.91629531 |
| 40 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.89815966 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.83735426 |
| 42 | T cell receptor signaling pathway (GO:0050852) | 3.80883884 |
| 43 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.75409708 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 3.75340487 |
| 45 | T cell homeostasis (GO:0043029) | 3.73103996 |
| 46 | tolerance induction (GO:0002507) | 3.72329700 |
| 47 | regulation of regulatory T cell differentiation (GO:0045589) | 3.65925590 |
| 48 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.65358745 |
| 49 | mast cell activation (GO:0045576) | 3.64212464 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.55844256 |
| 51 | T cell costimulation (GO:0031295) | 3.53330289 |
| 52 | detection of external biotic stimulus (GO:0098581) | 3.52746152 |
| 53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.49989331 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.49655118 |
| 55 | lymphocyte costimulation (GO:0031294) | 3.48117736 |
| 56 | mature B cell differentiation (GO:0002335) | 3.47076535 |
| 57 | neutrophil activation (GO:0042119) | 3.46799302 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.44710207 |
| 59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.42884764 |
| 60 | lymphocyte homeostasis (GO:0002260) | 3.40097965 |
| 61 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.39708559 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 3.38956873 |
| 63 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.36455711 |
| 64 | negative regulation of phagocytosis (GO:0050765) | 3.35224500 |
| 65 | NIK/NF-kappaB signaling (GO:0038061) | 3.28270801 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 3.27641362 |
| 67 | positive regulation of tolerance induction (GO:0002645) | 3.26748211 |
| 68 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.26010168 |
| 69 | mast cell activation involved in immune response (GO:0002279) | 3.25034507 |
| 70 | mast cell degranulation (GO:0043303) | 3.25034507 |
| 71 | granulocyte activation (GO:0036230) | 3.24742360 |
| 72 | positive regulation of interleukin-2 production (GO:0032743) | 3.23455232 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22602994 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 3.20822350 |
| 75 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.20071148 |
| 76 | leukocyte cell-cell adhesion (GO:0007159) | 3.19481582 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17181557 |
| 78 | response to host immune response (GO:0052572) | 3.16472809 |
| 79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.16472809 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.15925162 |
| 81 | B cell mediated immunity (GO:0019724) | 3.13355344 |
| 82 | positive regulation of granulocyte differentiation (GO:0030854) | 3.12136842 |
| 83 | detection of biotic stimulus (GO:0009595) | 3.11541780 |
| 84 | positive regulation of isotype switching (GO:0045830) | 3.11051795 |
| 85 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.10885559 |
| 86 | mannose metabolic process (GO:0006013) | 3.10650674 |
| 87 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.09177361 |
| 88 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.07493532 |
| 89 | activated T cell proliferation (GO:0050798) | 3.05714673 |
| 90 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.05033295 |
| 91 | B cell homeostasis (GO:0001782) | 3.04922387 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 3.04835263 |
| 93 | response to type I interferon (GO:0034340) | 3.04339787 |
| 94 | leukocyte homeostasis (GO:0001776) | 3.04322555 |
| 95 | cellular extravasation (GO:0045123) | 3.02234483 |
| 96 | leukocyte degranulation (GO:0043299) | 3.02217415 |
| 97 | defense response to protozoan (GO:0042832) | 3.01864390 |
| 98 | negative regulation of innate immune response (GO:0045824) | 3.01313314 |
| 99 | cellular response to zinc ion (GO:0071294) | 3.00258348 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98922992 |
| 101 | regulation of tolerance induction (GO:0002643) | 2.98858195 |
| 102 | mature B cell differentiation involved in immune response (GO:0002313) | 2.98692767 |
| 103 | response to protozoan (GO:0001562) | 2.98683208 |
| 104 | lymph node development (GO:0048535) | 2.97103456 |
| 105 | type I interferon signaling pathway (GO:0060337) | 2.96601037 |
| 106 | cellular response to type I interferon (GO:0071357) | 2.96601037 |
| 107 | B cell proliferation (GO:0042100) | 2.95602153 |
| 108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94185196 |
| 109 | response to host (GO:0075136) | 2.93909844 |
| 110 | response to host defenses (GO:0052200) | 2.93909844 |
| 111 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93909844 |
| 112 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.92819137 |
| 113 | microglial cell activation (GO:0001774) | 2.92259937 |
| 114 | regulation of response to interferon-gamma (GO:0060330) | 2.91717835 |
| 115 | macrophage activation (GO:0042116) | 2.90934839 |
| 116 | megakaryocyte development (GO:0035855) | 2.90525568 |
| 117 | regulation of mast cell activation (GO:0033003) | 2.90373469 |
| 118 | positive regulation of mast cell activation (GO:0033005) | 2.89981369 |
| 119 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89730574 |
| 120 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.88945421 |
| 121 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.88892904 |
| 122 | negative regulation of interleukin-6 production (GO:0032715) | 2.88721196 |
| 123 | negative regulation of T cell mediated immunity (GO:0002710) | 2.87640130 |
| 124 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.87389907 |
| 125 | regulation of granulocyte differentiation (GO:0030852) | 2.83583789 |
| 126 | natural killer cell activation (GO:0030101) | 2.82969687 |
| 127 | detection of molecule of bacterial origin (GO:0032490) | 2.82839804 |
| 128 | regulation of isotype switching (GO:0045191) | 2.82413518 |
| 129 | natural killer cell differentiation (GO:0001779) | 2.81508794 |
| 130 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80447282 |
| 131 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80447282 |
| 132 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.79231087 |
| 133 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.79231087 |
| 134 | myeloid dendritic cell activation (GO:0001773) | 2.78952837 |
| 135 | respiratory burst (GO:0045730) | 2.78394087 |
| 136 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78330858 |
| 137 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.78304832 |
| 138 | T cell proliferation (GO:0042098) | 2.77682686 |
| 139 | positive regulation of B cell activation (GO:0050871) | 2.77566844 |
| 140 | negative regulation of interleukin-12 production (GO:0032695) | 2.75399420 |
| 141 | ribosomal small subunit assembly (GO:0000028) | 2.74408361 |
| 142 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74391645 |
| 143 | regulation of B cell mediated immunity (GO:0002712) | 2.73733047 |
| 144 | positive regulation of immunoglobulin production (GO:0002639) | 2.69640347 |
| 145 | positive regulation of DNA recombination (GO:0045911) | 2.69253065 |
| 146 | regulation of B cell proliferation (GO:0030888) | 2.68077514 |
| 147 | germinal center formation (GO:0002467) | 2.68023518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.92747538 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.77440424 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.45148347 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.22066436 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73710304 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.70155530 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.57647274 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.31000258 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.18285142 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.01150353 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.89697117 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.88776897 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.87093064 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.76435171 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73272934 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.71618877 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.65330627 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.63669735 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59971877 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.56843716 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55185497 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54244573 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.52666586 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52161083 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.45108053 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36503132 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.34760941 |
| 28 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34004138 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.20108803 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.15942112 |
| 31 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.14483380 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11272379 |
| 33 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.08804417 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06983211 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04048305 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97499728 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89176235 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86595592 |
| 39 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.84130835 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82293029 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.82148789 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82086914 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.81011870 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79336066 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74050554 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72335790 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.68586481 |
| 48 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62515842 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56822187 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53192032 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49119809 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.48902701 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48258875 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42907532 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.41030789 |
| 56 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.37175765 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35950762 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35735838 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35601990 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35266522 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35049206 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32272037 |
| 63 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31606385 |
| 64 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.28367641 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27239685 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26728485 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26454570 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20889541 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20568916 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19922938 |
| 71 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18435535 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15187120 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14123540 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13949952 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13753247 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13560436 |
| 77 | P68_20966046_ChIP-Seq_HELA_Human | 1.12969528 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12416885 |
| 79 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.12360580 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11912724 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11843392 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.11725193 |
| 83 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11614114 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.11016396 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10909413 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10684474 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09464963 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09065372 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08548893 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08284437 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07515656 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06019468 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01395274 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00393753 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97591154 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94682241 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92371464 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92044893 |
| 99 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90378241 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88535608 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88528227 |
| 102 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.88029640 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87293547 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86254289 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86086436 |
| 106 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85975811 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84745693 |
| 108 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84699543 |
| 109 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.83633709 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.83081929 |
| 111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82258626 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81647585 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79467524 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.79124508 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77463323 |
| 116 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.76276314 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.72900133 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72836055 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72123665 |
| 120 | P300_27268052_Chip-Seq_Bcells_Human | 0.71198229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.14658036 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.89543620 |
| 3 | MP0005671_abnormal_response_to | 3.63345640 |
| 4 | MP0001800_abnormal_humoral_immune | 3.55731731 |
| 5 | MP0000685_abnormal_immune_system | 3.53666363 |
| 6 | MP0005387_immune_system_phenotype | 3.30213093 |
| 7 | MP0001790_abnormal_immune_system | 3.30213093 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.99892666 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.96325686 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.92752292 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.88543711 |
| 12 | MP0002723_abnormal_immune_serum | 2.86822398 |
| 13 | MP0001819_abnormal_immune_cell | 2.83646234 |
| 14 | MP0002398_abnormal_bone_marrow | 2.80987946 |
| 15 | MP0009785_altered_susceptibility_to | 2.70027905 |
| 16 | MP0003436_decreased_susceptibility_to | 2.64691308 |
| 17 | MP0003303_peritoneal_inflammation | 2.56096145 |
| 18 | MP0005025_abnormal_response_to | 2.53984019 |
| 19 | MP0000716_abnormal_immune_system | 2.48224060 |
| 20 | MP0001873_stomach_inflammation | 2.43342072 |
| 21 | MP0000689_abnormal_spleen_morphology | 2.39270430 |
| 22 | MP0002419_abnormal_innate_immunity | 2.34930464 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.32732035 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.30632108 |
| 25 | MP0002722_abnormal_immune_system | 2.29178858 |
| 26 | MP0002405_respiratory_system_inflammati | 2.24095211 |
| 27 | MP0000703_abnormal_thymus_morphology | 2.16709756 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.16436949 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 2.14326391 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 2.12576099 |
| 31 | MP0002429_abnormal_blood_cell | 2.08580992 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.99155393 |
| 33 | MP0006082_CNS_inflammation | 1.93235243 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.89158611 |
| 35 | MP0004947_skin_inflammation | 1.86843256 |
| 36 | MP0002006_tumorigenesis | 1.80114291 |
| 37 | MP0009278_abnormal_bone_marrow | 1.77374788 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.75988581 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.74203212 |
| 40 | MP0003866_abnormal_defecation | 1.74041110 |
| 41 | MP0008260_abnormal_autophagy | 1.69536558 |
| 42 | MP0001853_heart_inflammation | 1.67419654 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.66569779 |
| 44 | MP0003724_increased_susceptibility_to | 1.66255688 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.65412143 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.65412143 |
| 47 | MP0002933_joint_inflammation | 1.50243982 |
| 48 | MP0000490_abnormal_crypts_of | 1.41201335 |
| 49 | MP0005451_abnormal_body_composition | 1.41103868 |
| 50 | MP0004510_myositis | 1.39140672 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.37674258 |
| 52 | MP0005310_abnormal_salivary_gland | 1.29195558 |
| 53 | MP0008469_abnormal_protein_level | 1.23828843 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.18613279 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.17153451 |
| 56 | MP0009840_abnormal_foam_cell | 1.16560189 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.09891644 |
| 58 | MP0000858_altered_metastatic_potential | 1.08957710 |
| 59 | MP0002019_abnormal_tumor_incidence | 1.08600202 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.08549176 |
| 61 | MP0003075_altered_response_to | 1.05920494 |
| 62 | MP0008057_abnormal_DNA_replication | 1.05173067 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.05017621 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.03218005 |
| 65 | MP0005058_abnormal_lysosome_morphology | 0.99074059 |
| 66 | MP0003077_abnormal_cell_cycle | 0.97415589 |
| 67 | MP0010094_abnormal_chromosome_stability | 0.97301692 |
| 68 | MP0003690_abnormal_glial_cell | 0.95253782 |
| 69 | MP0001851_eye_inflammation | 0.94637567 |
| 70 | MP0004883_abnormal_blood_vessel | 0.94031831 |
| 71 | MP0003448_altered_tumor_morphology | 0.93045762 |
| 72 | MP0002132_abnormal_respiratory_system | 0.92054308 |
| 73 | MP0008004_abnormal_stomach_pH | 0.90693962 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.90306718 |
| 75 | MP0003693_abnormal_embryo_hatching | 0.88228249 |
| 76 | MP0000604_amyloidosis | 0.87015319 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 0.82577762 |
| 78 | MP0005390_skeleton_phenotype | 0.82464195 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.79140940 |
| 80 | MP0010307_abnormal_tumor_latency | 0.75578840 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.74461393 |
| 82 | MP0008058_abnormal_DNA_repair | 0.73728839 |
| 83 | MP0009764_decreased_sensitivity_to | 0.73306348 |
| 84 | MP0009763_increased_sensitivity_to | 0.69128129 |
| 85 | MP0005023_abnormal_wound_healing | 0.67744162 |
| 86 | MP0003795_abnormal_bone_structure | 0.67477889 |
| 87 | MP0005164_abnormal_response_to | 0.66534963 |
| 88 | MP0003111_abnormal_nucleus_morphology | 0.66194459 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.66185664 |
| 90 | MP0001663_abnormal_digestive_system | 0.65558851 |
| 91 | MP0008007_abnormal_cellular_replicative | 0.64976063 |
| 92 | MP0000313_abnormal_cell_death | 0.64277915 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.63759538 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.62390923 |
| 95 | MP0003828_pulmonary_edema | 0.61403747 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.60857936 |
| 97 | MP0004381_abnormal_hair_follicle | 0.59923061 |
| 98 | MP0000371_diluted_coat_color | 0.58030380 |
| 99 | MP0003091_abnormal_cell_migration | 0.57624932 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.57574292 |
| 101 | MP0008874_decreased_physiological_sensi | 0.57465047 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.56824928 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.55570472 |
| 104 | MP0000477_abnormal_intestine_morphology | 0.55366101 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.54592645 |
| 106 | MP0003045_fibrosis | 0.54191929 |
| 107 | MP0005381_digestive/alimentary_phenotyp | 0.53605603 |
| 108 | MP0000343_altered_response_to | 0.53502908 |
| 109 | MP0002928_abnormal_bile_duct | 0.52916897 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.52607449 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.51681200 |
| 112 | MP0000249_abnormal_blood_vessel | 0.51146850 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.49562613 |
| 114 | MP0002009_preneoplasia | 0.49158870 |
| 115 | MP0005166_decreased_susceptibility_to | 0.49084533 |
| 116 | MP0005535_abnormal_body_temperature | 0.48360952 |
| 117 | MP0000609_abnormal_liver_physiology | 0.48213143 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.46662523 |
| 119 | MP0004130_abnormal_muscle_cell | 0.46528135 |
| 120 | MP0009115_abnormal_fat_cell | 0.46242908 |
| 121 | MP0000350_abnormal_cell_proliferation | 0.45782574 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.44350098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 5.02036589 |
| 2 | Recurrent viral infections (HP:0004429) | 4.90501914 |
| 3 | T lymphocytopenia (HP:0005403) | 4.78151668 |
| 4 | Agammaglobulinemia (HP:0004432) | 4.77498624 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 4.72790493 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.70464425 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.64525369 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.57990092 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.52658233 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.44455784 |
| 11 | Chronic otitis media (HP:0000389) | 4.35040158 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.13786340 |
| 13 | Eczematoid dermatitis (HP:0000976) | 4.13448637 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 4.09285650 |
| 15 | Abnormality of T cells (HP:0002843) | 4.03945802 |
| 16 | Inflammation of the large intestine (HP:0002037) | 3.94509838 |
| 17 | Meningitis (HP:0001287) | 3.89490847 |
| 18 | Cellulitis (HP:0100658) | 3.84834149 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 3.82704569 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.82424784 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.82424784 |
| 22 | Colitis (HP:0002583) | 3.79322936 |
| 23 | Myositis (HP:0100614) | 3.72766801 |
| 24 | Abnormality of the fingertips (HP:0001211) | 3.69608474 |
| 25 | Pustule (HP:0200039) | 3.66281781 |
| 26 | Lymphopenia (HP:0001888) | 3.62556654 |
| 27 | Thyroiditis (HP:0100646) | 3.62060357 |
| 28 | B lymphocytopenia (HP:0010976) | 3.58218380 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.58218380 |
| 30 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.49694471 |
| 31 | Severe combined immunodeficiency (HP:0004430) | 3.39087699 |
| 32 | Nasal polyposis (HP:0100582) | 3.38037624 |
| 33 | Recurrent skin infections (HP:0001581) | 3.37970569 |
| 34 | Papilloma (HP:0012740) | 3.37131120 |
| 35 | Verrucae (HP:0200043) | 3.37131120 |
| 36 | Gastrointestinal stroma tumor (HP:0100723) | 3.35489832 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 3.30468655 |
| 38 | Recurrent sinusitis (HP:0011108) | 3.29778194 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 3.27979619 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 3.27750239 |
| 41 | Combined immunodeficiency (HP:0005387) | 3.25773518 |
| 42 | Thrombocytosis (HP:0001894) | 3.25242732 |
| 43 | Prolonged bleeding time (HP:0003010) | 3.24250249 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 3.20342489 |
| 45 | Vasculitis (HP:0002633) | 3.18140885 |
| 46 | IgG deficiency (HP:0004315) | 3.17870412 |
| 47 | Stomatitis (HP:0010280) | 3.12040392 |
| 48 | Eosinophilia (HP:0001880) | 3.09196432 |
| 49 | Abnormality of the nasal mucosa (HP:0000433) | 3.01653479 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.94731238 |
| 51 | Granulocytopenia (HP:0001913) | 2.91625870 |
| 52 | Chronic diarrhea (HP:0002028) | 2.90531467 |
| 53 | Abnormality of eosinophils (HP:0001879) | 2.89308657 |
| 54 | Urticaria (HP:0001025) | 2.87594352 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84994421 |
| 56 | Obstructive lung disease (HP:0006536) | 2.84994421 |
| 57 | Chronic sinusitis (HP:0011109) | 2.81130251 |
| 58 | Leukocytosis (HP:0001974) | 2.81046794 |
| 59 | Keratoconjunctivitis sicca (HP:0001097) | 2.77259673 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.74833808 |
| 61 | IgA deficiency (HP:0002720) | 2.62976326 |
| 62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59621193 |
| 63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59621193 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59621193 |
| 65 | Lymphoma (HP:0002665) | 2.59095764 |
| 66 | Encephalitis (HP:0002383) | 2.58127342 |
| 67 | Increased IgE level (HP:0003212) | 2.57625857 |
| 68 | Epistaxis (HP:0000421) | 2.56268837 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.56013246 |
| 70 | Emphysema (HP:0002097) | 2.55620094 |
| 71 | Bronchitis (HP:0012387) | 2.55264516 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53906372 |
| 73 | Abnormality of macrophages (HP:0004311) | 2.53511469 |
| 74 | Petechiae (HP:0000967) | 2.53388594 |
| 75 | Keratoconjunctivitis (HP:0001096) | 2.53314760 |
| 76 | Hypochromic anemia (HP:0001931) | 2.49475007 |
| 77 | Osteomyelitis (HP:0002754) | 2.48743936 |
| 78 | Hypoplasia of the thymus (HP:0000778) | 2.47654912 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.45568189 |
| 80 | Increased IgM level (HP:0003496) | 2.41314715 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.39917103 |
| 82 | Systemic lupus erythematosus (HP:0002725) | 2.37705263 |
| 83 | Loss of speech (HP:0002371) | 2.36809529 |
| 84 | Pulmonary embolism (HP:0002204) | 2.30506524 |
| 85 | Periodontitis (HP:0000704) | 2.29476050 |
| 86 | Purpura (HP:0000979) | 2.27576205 |
| 87 | Episodic fever (HP:0001954) | 2.27506494 |
| 88 | Basal cell carcinoma (HP:0002671) | 2.27330670 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.27315687 |
| 90 | Chest pain (HP:0100749) | 2.25175501 |
| 91 | Sepsis (HP:0100806) | 2.24672107 |
| 92 | Hepatosplenomegaly (HP:0001433) | 2.24252181 |
| 93 | Recurrent otitis media (HP:0000403) | 2.21884889 |
| 94 | Restrictive lung disease (HP:0002091) | 2.21596813 |
| 95 | Optic neuritis (HP:0100653) | 2.21199430 |
| 96 | Retrobulbar optic neuritis (HP:0100654) | 2.21199430 |
| 97 | Orchitis (HP:0100796) | 2.21039059 |
| 98 | Increased serum ferritin (HP:0003281) | 2.20461675 |
| 99 | Gingival bleeding (HP:0000225) | 2.19332887 |
| 100 | Gingivitis (HP:0000230) | 2.18569175 |
| 101 | Pulmonary infiltrates (HP:0002113) | 2.18388236 |
| 102 | Recurrent pneumonia (HP:0006532) | 2.16065877 |
| 103 | Hemoptysis (HP:0002105) | 2.15900216 |
| 104 | Amyloidosis (HP:0011034) | 2.15214327 |
| 105 | Viral hepatitis (HP:0006562) | 2.14037332 |
| 106 | Impaired platelet aggregation (HP:0003540) | 2.13266804 |
| 107 | Abnormal platelet function (HP:0011869) | 2.13266804 |
| 108 | Skin ulcer (HP:0200042) | 2.12729888 |
| 109 | Hypochromic microcytic anemia (HP:0004840) | 2.11243677 |
| 110 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10930322 |
| 111 | Abnormal platelet volume (HP:0011876) | 2.10288274 |
| 112 | Arterial thrombosis (HP:0004420) | 2.05946870 |
| 113 | Slow saccadic eye movements (HP:0000514) | 2.04543007 |
| 114 | Abnormality of the pleura (HP:0002103) | 2.03036153 |
| 115 | Premature loss of primary teeth (HP:0006323) | 2.00760247 |
| 116 | Papilledema (HP:0001085) | 1.98047980 |
| 117 | Hematochezia (HP:0002573) | 1.96469770 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.96207554 |
| 119 | Anorexia (HP:0002039) | 1.95912966 |
| 120 | Leukopenia (HP:0001882) | 1.95186289 |
| 121 | Abnormality of the prostate (HP:0008775) | 1.93607356 |
| 122 | Joint swelling (HP:0001386) | 1.92823775 |
| 123 | Polygenic inheritance (HP:0010982) | 1.92416282 |
| 124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92196722 |
| 125 | Microcytic anemia (HP:0001935) | 1.92174365 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.90830847 |
| 127 | Poikiloderma (HP:0001029) | 1.87638691 |
| 128 | Fatigue (HP:0012378) | 1.85209903 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85023655 |
| 130 | Vacuolated lymphocytes (HP:0001922) | 1.80680341 |
| 131 | Neutropenia (HP:0001875) | 1.80460283 |
| 132 | Cheilitis (HP:0100825) | 1.79437486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.13800187 |
| 2 | TXK | 3.53060743 |
| 3 | PRPF4B | 3.19609602 |
| 4 | TYK2 | 2.65597759 |
| 5 | ZAP70 | 2.57891360 |
| 6 | JAK3 | 2.50979842 |
| 7 | GRK6 | 2.48941129 |
| 8 | STK10 | 2.43619072 |
| 9 | MAP3K10 | 2.35444847 |
| 10 | BTK | 2.32646823 |
| 11 | IKBKE | 2.30969747 |
| 12 | ITK | 2.21830628 |
| 13 | KIT | 2.18879191 |
| 14 | BLK | 2.12339462 |
| 15 | CSF1R | 2.08848670 |
| 16 | SYK | 2.05004959 |
| 17 | IRAK4 | 1.98375254 |
| 18 | TEC | 1.86740204 |
| 19 | EEF2K | 1.83514149 |
| 20 | FGFR4 | 1.81435852 |
| 21 | TBK1 | 1.80591995 |
| 22 | MAP3K14 | 1.79551184 |
| 23 | MAP3K13 | 1.78101802 |
| 24 | LCK | 1.70974915 |
| 25 | JAK1 | 1.70642299 |
| 26 | SIK2 | 1.68486923 |
| 27 | MAP3K11 | 1.67096732 |
| 28 | TGFBR2 | 1.64925836 |
| 29 | HCK | 1.62974519 |
| 30 | ERN1 | 1.48677375 |
| 31 | RIPK4 | 1.44575723 |
| 32 | CSK | 1.43727461 |
| 33 | LRRK2 | 1.38300792 |
| 34 | FES | 1.35193700 |
| 35 | MAP3K3 | 1.34324948 |
| 36 | FGFR3 | 1.32639899 |
| 37 | IKBKB | 1.28585200 |
| 38 | FLT3 | 1.27194469 |
| 39 | MAP2K3 | 1.25665249 |
| 40 | NLK | 1.24449872 |
| 41 | LYN | 1.24383679 |
| 42 | CLK1 | 1.23253650 |
| 43 | PKN2 | 1.22884427 |
| 44 | FGR | 1.19631225 |
| 45 | SMG1 | 1.17343624 |
| 46 | MARK3 | 1.14348396 |
| 47 | MAP3K1 | 1.10367750 |
| 48 | PIM1 | 1.08599547 |
| 49 | IRAK3 | 1.02328012 |
| 50 | RPS6KA4 | 0.98259655 |
| 51 | TNK2 | 0.96532853 |
| 52 | TAOK2 | 0.95594130 |
| 53 | CDC42BPA | 0.94046575 |
| 54 | CDK12 | 0.91186724 |
| 55 | PRKCQ | 0.84124992 |
| 56 | NME2 | 0.82702956 |
| 57 | SIK3 | 0.78206190 |
| 58 | CDK4 | 0.77717158 |
| 59 | JAK2 | 0.75918774 |
| 60 | KDR | 0.75696348 |
| 61 | CHUK | 0.75204164 |
| 62 | STK4 | 0.74932677 |
| 63 | MST4 | 0.73951577 |
| 64 | PRKCH | 0.73307624 |
| 65 | BRD4 | 0.72638966 |
| 66 | EPHB1 | 0.72484215 |
| 67 | NEK2 | 0.71594019 |
| 68 | MAP3K6 | 0.70709453 |
| 69 | BMPR2 | 0.68298689 |
| 70 | PDPK1 | 0.65769175 |
| 71 | CAMKK1 | 0.65389797 |
| 72 | TRIB3 | 0.64726265 |
| 73 | TAOK3 | 0.63742519 |
| 74 | KSR2 | 0.62454470 |
| 75 | MAP3K7 | 0.61622500 |
| 76 | HIPK2 | 0.58772275 |
| 77 | TGFBR1 | 0.58740750 |
| 78 | TTN | 0.56497969 |
| 79 | IRAK1 | 0.56411951 |
| 80 | IRAK2 | 0.56255367 |
| 81 | TRPM7 | 0.55367301 |
| 82 | MAP2K6 | 0.54318738 |
| 83 | MAPK12 | 0.52023975 |
| 84 | DYRK1B | 0.51669284 |
| 85 | MAP2K2 | 0.51556604 |
| 86 | MAPK4 | 0.51068275 |
| 87 | TESK2 | 0.50510138 |
| 88 | MAPK11 | 0.48895129 |
| 89 | PDK1 | 0.47232051 |
| 90 | PTK6 | 0.43325566 |
| 91 | CAMKK2 | 0.42588193 |
| 92 | CDK19 | 0.42451385 |
| 93 | RPS6KA6 | 0.41459005 |
| 94 | PIK3CG | 0.41209748 |
| 95 | MAPK7 | 0.39421438 |
| 96 | RET | 0.39262122 |
| 97 | CAMK1D | 0.39127582 |
| 98 | MARK2 | 0.38250883 |
| 99 | CDK9 | 0.38178736 |
| 100 | BMX | 0.37787679 |
| 101 | ATR | 0.37508432 |
| 102 | CDK6 | 0.37335747 |
| 103 | ICK | 0.36526926 |
| 104 | RPS6KB2 | 0.35457054 |
| 105 | ABL1 | 0.35075147 |
| 106 | GRK7 | 0.34362384 |
| 107 | CAMK1G | 0.33715281 |
| 108 | PRKD2 | 0.32661338 |
| 109 | FYN | 0.32648754 |
| 110 | RPS6KA2 | 0.32495558 |
| 111 | PDGFRB | 0.32312678 |
| 112 | RPS6KC1 | 0.30248358 |
| 113 | RPS6KL1 | 0.30248358 |
| 114 | ALK | 0.28840375 |
| 115 | MAP3K8 | 0.28158208 |
| 116 | MATK | 0.26035963 |
| 117 | MAPK3 | 0.25722454 |
| 118 | SGK3 | 0.24364460 |
| 119 | YES1 | 0.23934159 |
| 120 | MAPKAPK2 | 0.23328068 |
| 121 | PASK | 0.22916513 |
| 122 | EGFR | 0.22817698 |
| 123 | INSR | 0.22595474 |
| 124 | STK24 | 0.22462160 |
| 125 | TAOK1 | 0.21909748 |
| 126 | SIK1 | 0.21506409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.08640132 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.27214169 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.67319036 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.59988615 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.51174409 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.48076728 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41876339 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39231226 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.38589346 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.29783239 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27326653 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.25567731 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.89713870 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.87447451 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.84628982 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75062249 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.72273257 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68755377 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60463013 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56555255 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49012310 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.46237278 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45526585 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44529388 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43040784 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41119697 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39443140 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.35966272 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35687871 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34239560 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.32705684 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.32663419 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.30368961 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26800386 |
| 35 | Base excision repair_Homo sapiens_hsa03410 | 1.26197640 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.20240903 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.19392395 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18610042 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.16886832 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.14786107 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.13805293 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.13779803 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12446249 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08411424 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07467521 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07126286 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.04982106 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 1.04257224 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02639874 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 1.02597084 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99521922 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 0.95040126 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94915417 |
| 54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92035515 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90914907 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.90757993 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.87855842 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84294034 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81883906 |
| 60 | Spliceosome_Homo sapiens_hsa03040 | 0.80899212 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80088496 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78058509 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75524704 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74931090 |
| 65 | Homologous recombination_Homo sapiens_hsa03440 | 0.74695746 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.73463933 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.70606252 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69203433 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69035181 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68351671 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68297008 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67433963 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66866517 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63369464 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62898676 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62649988 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60910747 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59920631 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57299136 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56905110 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56823454 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56752072 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56315295 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52805371 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.51444222 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51054622 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51004393 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48996568 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48698993 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48028656 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.47956331 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.47477785 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46948663 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46825417 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.41151335 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40388467 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.40207623 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40078579 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40021338 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.39949514 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.38813433 |
| 102 | Cell cycle_Homo sapiens_hsa04110 | 0.38712713 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37494917 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35886906 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35860177 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35313021 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33665663 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33193060 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33166817 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32073141 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31687479 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.31016512 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.30779916 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30678431 |
| 115 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30150328 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29950356 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28359484 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.27970963 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.27954984 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27525004 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26935994 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26047876 |

